1.40
price up icon3.70%   0.05
after-market 시간 외 거래: 1.51 0.11 +7.86%
loading
전일 마감가:
$1.35
열려 있는:
$1.35
하루 거래량:
24,124
Relative Volume:
0.01
시가총액:
$4.51M
수익:
-
순이익/손실:
$-6.71M
주가수익비율:
-3.1963
EPS:
-0.438
순현금흐름:
$-8.81M
1주 성능:
-7.89%
1개월 성능:
-9.09%
6개월 성능:
-47.70%
1년 성능:
+299.89%
1일 변동 폭
Value
$1.35
$1.65
1주일 범위
Value
$1.29
$1.65
52주 변동 폭
Value
$0.2635
$7.00

Xortx Therapeutics Inc Stock (XRTX) Company Profile

Name
명칭
Xortx Therapeutics Inc
Name
전화
-
Name
주소
-
Name
직원
3
Name
트위터
Name
다음 수익 날짜
2024-11-12
Name
최신 SEC 제출 서류
Name
XRTX's Discussions on Twitter

Xortx Therapeutics Inc 주식(XRTX)의 최신 뉴스

pulisher
Oct 24, 2024

XORTX Highlights Kidney Disease Study at ASN - TipRanks

Oct 24, 2024
pulisher
Oct 24, 2024

XORTX Sponsored Study Presented at the American Society of Nephrology – Kidney Week 2024 - GlobeNewswire

Oct 24, 2024
pulisher
Oct 18, 2024

XORTX Secures $1.5 Million in Latest Offering - TipRanks

Oct 18, 2024
pulisher
Oct 18, 2024

XORTX Announces Closing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewswire

Oct 18, 2024
pulisher
Oct 17, 2024

XORTX Therapeutics stock falls after pricing $1.5M capital raise - MSN

Oct 17, 2024
pulisher
Oct 17, 2024

XORTX Therapeutics Announces $1.5 Million Offering - TipRanks

Oct 17, 2024
pulisher
Oct 17, 2024

XORTX Announces Pricing of US$1.5 Million Registered Direct Offering and Concurrent Private Placement - GlobeNewswire

Oct 17, 2024
pulisher
Oct 16, 2024

The Significance of Moving Averages in XORTX Therapeutics Inc Inc. (XRTX) Price Performance - The InvestChronicle

Oct 16, 2024
pulisher
Oct 09, 2024

XORTX Therapeutics Advances Precision Kidney Care - TipRanks

Oct 09, 2024
pulisher
Oct 09, 2024

XORTX Initiates Precision Medicine Program - GlobeNewswire

Oct 09, 2024
pulisher
Oct 09, 2024

XORTX Therapeutics Inc. Initiates Precision Medicine Program - Marketscreener.com

Oct 09, 2024
pulisher
Oct 08, 2024

S&P 500 Financials [Sector] (SRFI) QuotePress Release - The Globe and Mail

Oct 08, 2024
pulisher
Oct 02, 2024

TSX 60 Shariah Index (TXSI) QuotePress Release - The Globe and Mail

Oct 02, 2024
pulisher
Sep 27, 2024

XORTX Therapeutics (NASDAQ:XRTX) Stock Quotes, Forecast and News Summary - Benzinga

Sep 27, 2024
pulisher
Sep 24, 2024

SEC Form 424B3 filed by XORTX Therapeutics Inc. - Quantisnow

Sep 24, 2024
pulisher
Sep 24, 2024

Form 424B3 XORTX Therapeutics Inc. - StreetInsider.com

Sep 24, 2024
pulisher
Sep 13, 2024

XORTX Therapeutics Shareholders Approve Key Decisions - TipRanks

Sep 13, 2024
pulisher
Sep 13, 2024

XORTX Announces Results of Annual and Special Meeting of Shareholders - GlobeNewswire

Sep 13, 2024
pulisher
Sep 12, 2024

Tesla Inc (TSLA-Q) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 12, 2024

XORTX Announces Re-filing of YE 2023 and Q2 2024 MD&A - GlobeNewswire

Sep 12, 2024
pulisher
Sep 12, 2024

S&P 500 Index (INX) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 12, 2024

Ford Motor Company (F-N) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 12, 2024

S&P 500 Communication Services [Sector] (SRTS) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 12, 2024

Dow Jones Industrials Average (DOWI) QuotePress Release - The Globe and Mail

Sep 12, 2024
pulisher
Sep 07, 2024

XORTX Prepares for Shareholders’ Vote on Key Resolutions - TipRanks

Sep 07, 2024
pulisher
Sep 06, 2024

XORTX Reminds Shareholders of Voting Deadline for Upcoming Annual and Special Meeting of Shareholders - GlobeNewswire

Sep 06, 2024
pulisher
Sep 05, 2024

In the Green: XORTX Therapeutics Inc (XRTX) Closes at 2.38, Up/Down 7.69 from Previous Day - The Dwinnex

Sep 05, 2024
pulisher
Sep 04, 2024

Atara Biotherapeutics (ATRA) Secures Strategic Investments to Advance T-cell Immunotherapy Innovations - BP Journal

Sep 04, 2024
pulisher
Sep 04, 2024

Views of Wall Street’s Leading Experts on XORTX Therapeutics Inc - SETE News

Sep 04, 2024
pulisher
Sep 03, 2024

XORTX Recommended by ISS for Shareholder Approval - TipRanks

Sep 03, 2024
pulisher
Sep 03, 2024

XORTX Therapeutics Inc (XRTX) Stock: The Story of a 52-Week Stock Range - The InvestChronicle

Sep 03, 2024
pulisher
Sep 03, 2024

Independent Proxy Advisory Firm ISS Recommends XORTX - GlobeNewswire

Sep 03, 2024
pulisher
Sep 03, 2024

Independent Proxy Advisory Firm ISS Recommends XORTX Shareholders Vote FOR ALL Proposed Items at the Upcoming Annual and Special Meeting of Shareholders - Yahoo Finance

Sep 03, 2024
pulisher
Aug 31, 2024

Immersion Corp (NASDAQ: IMMR): An Enticing Stock To Watch - Stocks Register

Aug 31, 2024
pulisher
Aug 31, 2024

Comstock Inc (AMEX: LODE) Has Great Upside Potential - Stocks Register

Aug 31, 2024
pulisher
Aug 30, 2024

Value of company developing kidney disease treatments doubles in one day - Kursiv Media

Aug 30, 2024
pulisher
Aug 30, 2024

Pre-market Movers: BNRG, NCNA, PALT, ESTC, LUNR… - RTTNews

Aug 30, 2024
pulisher
Aug 30, 2024

U.S. shares mixed at close of trade; Dow Jones Industrial Average up 0.59% - MSN

Aug 30, 2024
pulisher
Aug 29, 2024

XORTX Therapeutics Inc Inc. (XRTX) Price Performance: A Technical Analysis Perspective - The InvestChronicle

Aug 29, 2024
pulisher
Aug 29, 2024

Wall Street-Heavily Traded - WDRB

Aug 29, 2024
pulisher
Aug 29, 2024

XORTX Therapeutics Gain 87% Following Publication of Research Supporting Treatment Pipeline - MarketWatch

Aug 29, 2024
pulisher
Aug 29, 2024

XORTX Therapeutics (XRTX) Stock Up On Major Research Development - Stocks Telegraph

Aug 29, 2024
pulisher
Aug 29, 2024

BioCardia Inc (Nasdaq: BCDA) Achieves Significant FDA Clearance for Morph DNA Steerable Introducer, Paving New Pathways in Cardiovascular Interventions - BP Journal

Aug 29, 2024
pulisher
Aug 29, 2024

XORTX Therapeutics Inc ($XRTX): Pioneering New Treatments for Kidney Disease with a Precision-Medicine Approach - BP Journal

Aug 29, 2024
pulisher
Aug 29, 2024

Nasdaq Surges Over 1%; Best Buy Posts Upbeat Earnings - Benzinga

Aug 29, 2024
pulisher
Aug 29, 2024

XORTX’s Research Reinforces Kidney Disease Treatment Strategy - TipRanks

Aug 29, 2024
pulisher
Aug 29, 2024

XRTX’s valuation metrics: A comprehensive analysis - US Post News

Aug 29, 2024
pulisher
Aug 29, 2024

Dow Jumps Over 100 Points; Nvidia Earnings Top Views - MSN

Aug 29, 2024
pulisher
Aug 29, 2024

Earnings and a potential kidney disease breakthrough - RagingBull

Aug 29, 2024
pulisher
Aug 29, 2024

XORTX Highlights Pioneering Research Indicating a Role for - GlobeNewswire

Aug 29, 2024
pulisher
Aug 29, 2024

XORTX Highlights Pioneering Research Indicating a Role for Genetic Regulation of Xanthine Oxidase and Therapeutic Targeting of Aberrant Purine Metabolism - StockTitan

Aug 29, 2024

Xortx Therapeutics Inc (XRTX) 재무 분석

매출

loading

순이익

loading

현금흐름

loading

주당 순 이익

loading
$77.28
price up icon 2.02%
$20.39
price up icon 2.15%
$382.77
price up icon 1.58%
$53.29
price down icon 0.47%
$208.03
price up icon 0.38%
$110.97
price up icon 1.84%
자본화:     |  볼륨(24시간):